Catalyst Wire Dossier Catalyst Wire Dossier

IC265 Ophthalmic Solution

· Iacta Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IC265 Ophthalmic Solution, covering 2025-04-25 to 2025-04-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants [Phase 2]

See pricing